Germany· DE-A57-4c556748b666497e
Ophel
A opipramol product containing opipramol hydrochloride, registered in Germany by Aenova Ip Gmbh. The same ATC class is registered in 5 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Opipramol is registered in 5 of 19 countries.
Countries holding a registration under ATC N06AA05 (opipramol), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 4 of them publish a price we can compare per daily dose
Opipramol · ATC N06AA05
5 / 19 countries
- Finlandprice
- Germany
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Opipramol Hydrochloride
- Manufacturer
- Aenova Ip Gmbh
- Country
- Germany (DE)
- ATC code
- N06AA05
- ATC class
- Opipramol
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
36 interactions on record for opipramol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Opipramol · interactions on record
36 records
36 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Opipramol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Austria · Insidon
- Poland · Apropol, Pramolan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6277766d-4cd9-4a12-8c9c-b5c0d8d62b45 GET /v1/drugs/6277766d-4cd9-4a12-8c9c-b5c0d8d62b45?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Opipramol Hydrochloride",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about opipramol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.